levofloxacin has been researched along with Nasal Catarrh in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Božić, DD; Ćirković, I; Čolović, J; Jotić, A; Milovanović, J; Pavlović, B | 1 |
Barion, U; Brescia, G; Munari, S; Zanotti, C | 1 |
Fokkens, WJ; Reitsma, JB; van Drunen, CM; Videler, WJ | 1 |
Abuzeid, WM; Chiu, AG; Doghramji, L; Edelstein, PH; Guss, J | 1 |
Anon, JB | 1 |
Bottin, R; Furlanut, M; Marioni, G; Pavan, F; Pea, F; Staffieri, A; Staffieri, C | 1 |
de Caprariis, PJ; Marple, BF; Reisman, A; Roberts, CS | 1 |
1 review(s) available for levofloxacin and Nasal Catarrh
Article | Year |
---|---|
Current management of acute bacterial rhinosinusitis and the role of moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Levofloxacin; Meta-Analysis as Topic; Moxifloxacin; Ofloxacin; Practice Guidelines as Topic; Quinolines; Rhinitis; Sinusitis; Streptococcus pneumoniae | 2005 |
1 trial(s) available for levofloxacin and Nasal Catarrh
Article | Year |
---|---|
Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacitracin; Chronic Disease; Colistin; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Nebulizers and Vaporizers; Ofloxacin; Pilot Projects; Rhinitis; Sinusitis; Staphylococcal Infections; Staphylococcus aureus | 2008 |
5 other study(ies) available for levofloxacin and Nasal Catarrh
Article | Year |
---|---|
Antibiofilm effects of amoxicillin-clavulanic acid and levofloxacin in patients with chronic rhinosinusitis with nasal polyposis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Biofilms; Chronic Disease; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Nasal Polyps; Rhinitis; Sinusitis | 2018 |
Burkholderia gladioli sinonasal infection.
Topics: Anti-Bacterial Agents; Burkholderia gladioli; Burkholderia Infections; Endoscopy; Female; Humans; Immunocompetence; Levofloxacin; Maxillary Sinusitis; Middle Aged; Rhinitis; Staphylococcal Infections; Travel-Related Illness | 2019 |
Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitis.
Topics: Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Comorbidity; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Outpatients; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Rhinitis; Sinusitis; Surgical Wound Infection | 2009 |
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose.
Topics: Adult; Aged; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Levofloxacin; Male; Middle Aged; Mucous Membrane; Ofloxacin; Paranasal Sinuses; Rhinitis; Sinusitis | 2007 |
Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Randomized Controlled Trials as Topic; Retrospective Studies; Rhinitis; Sinusitis; Treatment Outcome | 2007 |